---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-088165"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2026-08-12T15:50:09+00:00"
generated_at: "2026-08-12T15:51:06.485561+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma postpones BioKey share distribution to Aug 21, 2026

## Summary
- Distribution of BioKey (Cayman) ordinary shares moved from Aug 3 to Aug 21, 2026.
- Record date remains July 24, 2026; ratio unchanged at 0.169464 BioKey shares per ABVC share.
- Ex-dividend date will be revised and announced after administrative, regulatory, and tax matters are completed.
- Company coordinated with Nasdaq, DTC, and transfer agent on revised distribution mechanics.

## SEC filing metadata
- accession: 0001213900-26-088165
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2026-08-12T15:50:09+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/0001213900-26-088165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/ea0301755-8ka1_abvc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-088165
- JSON: https://secwatch.observer/filing/0001213900-26-088165.json
- Plain text: https://secwatch.observer/filing/0001213900-26-088165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.